49 US states have filed price fixing charges against 20 generic pharmaceutical companies and 15 other individual defendants on Friday. (Shutterstock)Drug majors Aurobindo Pharma and Dr Reddy’s Laboratories on Tuesday said they were preparing their legal defence to the charges of price fixing in the US market. As many as 49 US states have filed price fixing charges against 20 generic pharmaceutical companies and 15 other individual defendants on Friday. Besides DRL and Aurobindo, charges have been filed against five other Indian companies — Glenmark, Lupin, Wockhardt, Zydus and Sun Pharma’s US arm Taro. The Aurobindo share price fell Rs 2.10, or 0.29 per cent, to Rs 715.20 on the BSE.

Source: The Telegraph May 14, 2019 19:18 UTC